Until now, Lamictal was not considered a treatment for them.
The trial focused on people aged between two and 20. Lead researcher, Edwin Trevathan of St. Louis Children's Hospital,
said, "These study findings are important since physicians and
neurologists continue to have limited treatment options available for
generalized seizures in this age group."